Rebekah Amborski
Nurse Practitioner · Westerville, OHNPI 1740653377
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $44,950 of the $51,844 with a category attached, or 86.7%. AstraZeneca accounts for 95.5% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2021 at $26,485 and has fallen 91.7% since, to $2,186 in 2025. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $576.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$49K
- Bayer$2K
- GSK$166
What the payments were for
- Consulting fees$1,8153%
- Speaking & faculty fees$44,95087%
- Travel & lodging$2,4355%
- Food & beverage$2,6445%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 81 | $49,493 |
| Bayer | 5 | $2,186 |
| GSK | 4 | $166 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$51,844 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $8,361 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $278 |
| Pantoprazole Sodium | 16 | $181 |
| Gabapentin | 16 | $178 |
| Torsemide | 17 | $176 |
| Furosemide | 35 | $155 |
| Prednisone | 82 | $142 |
| Duloxetine Hcl | 11 | $138 |
| Fluconazole | 23 | $133 |
| Losartan Potassium | 17 | $126 |
| Mupirocin | 23 | $100 |
| Levofloxacin | 42 | $91 |
| Amlodipine Besylate | 17 | $84 |
| Atorvastatin Calcium | 14 | $83 |
| Carvedilol | 14 | $74 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Westerville
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.